Kyverna Therapeutics, Inc. (KYTX) vs Ocugen, Inc. (OCGN)
A side-by-side comparison of Kyverna Therapeutics, Inc. and Ocugen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KYTX
Kyverna Therapeutics, Inc.
$6.33HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
OCGN
Ocugen, Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — KYTX vs OCGN
growth of $100 · dividends reinvested · last 3yKYTX -78.9% (-40.5%/yr)OCGN +100.0% (+26.0%/yr)OCGN compounded faster over this window
Log scale — wide-divergence pair
KYTX OCGN
KYTX vs OCGN: by the numbers
- •KYTX is the larger company ($385M vs $359M market cap).
- •Both run net losses; KYTX's is the smaller (0.00% vs -1786.27% net margin).
Metrics side by side
Valuation
| Metric | KYTX | OCGN |
|---|---|---|
| P/S ratio | N/A | 78.48 |
| P/B ratio | 2.32 | N/A |
Profitability
| Metric | KYTX | OCGN |
|---|---|---|
| Gross margin | 0.00% | 45.86% |
| Operating margin | 0.00% | -1425.70% |
| Net margin | 0.00% | -1786.27% |
| ROE | -92.20% | N/A |
| ROIC | -80.67% | -93.74% |
Growth (annualized)
| Metric | KYTX | OCGN |
|---|---|---|
| Total return CAGR (5Y) | N/A | -31.57% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.